124 results on '"Pinto, Valeria Maria"'
Search Results
2. Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
3. Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations
4. Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization
5. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β‐thalassemia patient treated with thalidomide
6. Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato‐Oncologia Pediatrica) study group
7. Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values
8. PB2530: DIXON-BASED R2* MRI AS AN INTEGRATION/SUBSTITUTE OF STANDARD T2*/R2* IN THE EVALUATION OF IRON OVERLOAD IN THE UPPER ABDOMEN
9. Sickle cell disease: a review for the internist
10. Management of the Sickle Cell Trait: An Opinion by Expert Panel Members
11. Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato‐Oncologia Pediatrica) study group.
12. Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID ‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients
13. Reply to “Hepatocellular carcinoma in thalassemia and other hemoglobinopathies”
14. Coinheritance of PIEZO1 variants and multi‐locus red blood cell defects account for the symptomatic phenotype in beta‐thalassemia carriers
15. Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021
16. Effect of Aging on Deferasirox Therapy in Transfusion-dependent Patients. A Prospective- Retrospective, Cohort-study
17. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
18. Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting
19. Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy
20. Lack of correlation between heart, liver and pancreas MRI‐R2*: Results from long‐term follow‐up in a cohort of adult β‐thalassemia major patients
21. Comparison between different software programs and post-processing techniques for the MRI quantification of liver iron concentration in thalassemia patients
22. Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years.
23. Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry
24. Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy
25. Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia
26. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-Thalassemia: additional dose role
27. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection
28. Hemoglobin A2 and Heterogeneous Diagnostic Relevance Observed in Eight New Variants of the Delta Globin Gene
29. Hemoglobinopathies and Cancer: Preliminary Results of an Italian Multicenter Experience
30. Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021.
31. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β‐thalassemia patient treated with thalidomide.
32. Thalassemia Is Paradoxically Associated with a Reduced Risk of In-Hospital Complications and Mortality in COVID-19: Data from an International Registry
33. Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series
34. COVID 19 and Hemoglobinopathies: Update of the Italian Experience
35. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection.
36. Development of Algorithm for Clinical Management of Sickle Cell Bone Disease: Evidence for a Role of Vertebral Fractures in Patient Follow-up
37. Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm
38. Management of the aging beta-thalassemia transfusion-dependent population – The Italian experience
39. Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients
40. Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients
41. Criticità del D. M. 509
42. Hemoglobin A 2 and Heterogeneous Diagnostic Relevance Observed in Eight New Variants of the Delta Globin Gene.
43. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
44. Coinheritance of PIEZO1 variants and multi‐locus red blood cell defects account for the symptomatic phenotype in beta‐thalassemia carriers
45. Reply to 'Hepatocellular carcinoma in thalassemia and other hemoglobinopathies'
46. Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations
47. Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy
48. Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection
49. Thalassemia Is Paradoxically Associated with a Reduced Risk of In-Hospital Complications and Mortality in COVID-19: Data from an International Registry
50. Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.